Corbus Pharmaceuticals Holdings, Inc.
Ticker: 1595097
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2021 | Q3 FY2021 | Q2 FY2021 | Q2 FY2021 | Q1 FY2021 | Q1 FY2021 |
|---|---|---|---|---|---|---|
| INCOME | ||||||
| Revenue | 0.10+0.0% | 0.10-28.6% | 0.14+0.0% | 0.14-78.5% | 0.65+0.0% | 0.65 |
| Total Income | 0.10+0.0% | 0.10-28.6% | 0.14+0.0% | 0.14-78.5% | 0.65+0.0% | 0.65 |
| EXPENSES | ||||||
| Expenditure | 13.97+0.0% | 13.97-17.0% | 16.84+0.0% | 16.84+4.9% | 16.06+0.0% | 16.06 |
| PROFIT | ||||||
| Net Profit | -2.18+0.0% | -2.18+87.3% | -17.14+0.0% | -17.14-6.7% | -16.07+0.0% | -16.07 |
| KEY METRICS | ||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.02+0.0% | -0.02+86.7% | -0.15+0.0% | -0.15-7.1% | -0.14 | — |
Corporate Events
Board MeetingCRBP
202630Jun
Board Meeting
CMO Resignation — Dominic Smethurst resigned as Chief Medica…
SEC Filing ↗ Board MeetingCRBP
202621May
Board Meeting
Appointment of Nishant Saxena as Chief Business Officer and …
SEC Filing ↗ Board MeetingCRBP
202613May
Board Meeting
Brent Pfeiffenberger appointed to the Board of Directors; An…
SEC Filing ↗